Jiangxi Fushine Pharmaceutical Co., Ltd. (300497.SZ)
CNY 9.12
(-0.44%)
CNY 9.12
(-0.44%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.6 Billion | 1.64 Billion | 1.42 Billion | 1.49 Billion | 1.35 Billion | 1.16 Billion |
| Cost of Revenue | 1.47 Billion | 1.35 Billion | 993.55 Million | 889.23 Million | 770.34 Million | 730.01 Million |
| Gross Profit | 138.32 Million | 297.1 Million | 435.98 Million | 603.71 Million | 583.7 Million | 433.41 Million |
| Operating Expenses | 367.7 Million | 259.41 Million | 229.76 Million | 170.29 Million | 173.89 Million | 177.92 Million |
| Selling, General and Administrative Expenses | 194.46 Million | 76.96 Million | 71.17 Million | 52.17 Million | 57.11 Million | 50.35 Million |
| Research and Development Expenses | 97.45 Million | 77.45 Million | 78.51 Million | 76.52 Million | 59.45 Million | 52.87 Million |
| Other Expenses | 75.79 Million | -87.53 Million | -85.98 Million | -8.18 Million | -10.9 Million | -4.08 Million |
| Cost and Expenses | 1.83 Billion | 1.6 Billion | 1.22 Billion | 1.05 Billion | 944.23 Million | 907.94 Million |
| Operating Income | -229.38 Million | -133.95 Million | 57 Million | 386.99 Million | 369.26 Million | 231.16 Million |
| Interest Expense | 42.03 Million | 41.09 Million | 24.91 Million | 23.73 Million | 33.1 Million | 24.05 Million |
| Income Tax Expense | -9.91 Million | 21.46 Million | 15.53 Million | 56.63 Million | 51.47 Million | 34.71 Million |
| Earnings before Tax | -233.17 Million | -142.7 Million | 55.06 Million | 378.81 Million | 358.35 Million | 227.07 Million |
| Net Income | -200.8 Million | -141.47 Million | 48.83 Million | 319.3 Million | 305.83 Million | 194.72 Million |
| Earnings Per Share Basic | -0.37 | -0.26 | 0.09 | 0.70 | 0.71 | 0.46 |
| Earnings Per Share Diluted | -0.37 | -0.26 | 0.09 | 0.69 | 0.67 | 0.45 |
| Weighted Average Shares Outstanding | 542.7 Million | 538.64 Million | 544.2 Million | 456.14 Million | 427.96 Million | 426.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 542.7 Million | 538.64 Million | 544.2 Million | 462.75 Million | 456.47 Million | 432.72 Million |
| Gross Margin | 0.09 | 0.18 | 0.30 | 0.40 | 0.43 | 0.37 |
| EBIT Margin | -0.01 | 0.07 | 0.13 | 0.32 | 0.35 | 0.27 |
| Profit Margin | -0.12 | -0.09 | 0.03 | 0.21 | 0.23 | 0.17 |
| EBITDA | -18.49 Million | 22.22 Million | 178.55 Million | 476.48 Million | 457.99 Million | 303.96 Million |
| Earnings Before Tax Margin | -0.14 | -0.08 | 0.04 | 0.26 | 0.27 | 0.20 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 294.46 Million | 341.98 Million | 340.43 Million | 1.6 Billion | 323.23 Million | 430.79 Million |
| Cost of Revenue | 268.55 Million | 322.55 Million | 288.91 Million | 1.43 Billion | 296.88 Million | 369.01 Million |
| Gross Profit | 25.9 Million | 19.42 Million | 51.51 Million | 171.05 Million | 26.34 Million | 61.78 Million |
| Operating Expenses | 58.05 Million | 35.38 Million | 40.35 Million | 302.99 Million | 100.42 Million | 71.49 Million |
| Selling, General and Administrative Expenses | 86.45 Million | -8.48 Million | 31.68 Million | - | -49.87 Million | 88.74 Million |
| Research and Development Expenses | 20.14 Million | 18.85 Million | 15.87 Million | - | 33.95 Million | 23.86 Million |
| Other Expenses | -48.55 Million | 121.03 Thousand | -273.77 Thousand | -3.78 Million | -3.12 Million | 1.28 Million |
| Cost and Expenses | 326.61 Million | 357.94 Million | 329.26 Million | 1.74 Billion | 397.3 Million | 440.5 Million |
| Operating Income | -41.46 Million | -25.47 Million | 4.1 Million | -229.38 Million | -143.32 Million | -18.17 Million |
| Interest Expense | 9.85 Million | 9.93 Million | 10.8 Million | 42.03 Million | 10.49 Million | 10.76 Million |
| Income Tax Expense | 536.32 Thousand | 932.47 Thousand | 4.56 Million | -9.91 Million | -16.09 Million | 6.14 Million |
| Earnings before Tax | -41.64 Million | -25.35 Million | 3.82 Million | -233.17 Million | -146.44 Million | -18.82 Million |
| Net Income | -39.61 Million | -23.92 Million | 1.46 Million | -200.8 Million | -119.16 Million | -21.96 Million |
| Earnings Per Share Basic | -0.07 | -0.04 | 0.00 | - | -0.22 | -0.04 |
| Earnings Per Share Diluted | -0.07 | -0.04 | 0.00 | - | -0.22 | -0.04 |
| Weighted Average Shares Outstanding | 538.64 Million | 538.64 Million | 489.48 Million | 542.7 Million | 538.07 Million | 538.64 Million |
| Weighted Average Shares Outstanding (Diluted) | 538.64 Million | 538.64 Million | 489.48 Million | 542.7 Million | 538.07 Million | 538.64 Million |
| Gross Margin | 0.09 | 0.06 | 0.15 | 0.11 | 0.08 | 0.14 |
| EBIT Margin | -0.11 | -0.04 | 0.04 | - | -0.27 | -0.02 |
| Profit Margin | -0.13 | -0.07 | 0.00 | -0.12 | -0.37 | -0.05 |
| EBITDA | -31.79 Million | -12.91 Million | 15.07 Million | - | -88.7 Million | -7.42 Million |
| Earnings Before Tax Margin | -0.14 | -0.07 | 0.01 | -0.14 | -0.44 | -0.04 |
LFDJF
300956
AREIT
3737
TEP
PSMMY